Broadly cross-reactive neutralizing and enhancing antibody responses to dengue, Japanese encephalitis viruses and Zika in sera from Vietnamese pediatric dengue cases.

Authors

Muhareva Raekiansyah, Mya Myat Ngwe Tun, Jean Claude Balingit, Thi Thanh Ngan Nguyen, Thanh Vu Nguyen, Merveille Kapandji, Yuki Takamatsu, Takeshi Urano, Thi Quynh Mai Le, Futoshi Hasebe, Kouichi Morita

Published in

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases. Pages 109000. Jul 27, 2026. Epub Jul 27, 2026.

Abstract

Understanding the balance between protective and pathogenic antibody responses is central to dengue immunology and flavivirus vaccine development.
Fifty paired acute and convalescent serum samples from pediatric dengue patients in southern Vietnam (2015-2017) were analyzed, including primary and secondary infections across a spectrum of disease severity. Primary and secondary DENV infections were classified using an in-house validated DENV IgG ELISA. Neutralizing antibody (NAb) titers and antibody-dependent enhancement (ADE) activities were evaluated against dengue virus the four serotypes (DENV), Japanese encephalitis virus (JEV) and ZIKA (ZIKV) using single-round infectious particles (SRIPs).
Neutralizing antibody (NAb) responses were detected against all DENV serotypes and were highest against DENV-1. NAb titers increased during convalescence and were generally higher in secondary than primary infections. Higher NAb titers were also observed in convalescent sera from DSS cases compared with other clinical groups. ADE activity was most pronounced against DENV-2 and was lowest against DENV-4, while Peak enhancement titers (PET) were higher in convalescent samples, secondary infections, and DSS cases, and were positively correlated with NAb titers. Additionally, higher enhancement activity was observed in sera from DSS cases than in those from milder disease categories. Cross-reactive neutralizing and enhancing antibodies against JEV and ZIKV were also detected, with stronger enhancement observed against ZIKV.
Heightened neutralizing immunity in secondary and severe dengue is accompanied by expanded enhancement potential, indicating an expanded, cross-reactive immune response driven by immune activation upon infection. The coexistence of protective and enhancing antibodies may contribute both to viral control and to immunopathogenesis during subsequent flavivirus infections.

PMID:
42508521
Bibliographic data and abstract were imported from PubMed on 28 Jul 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.